Up 17% in October – is this unsung FTSE hero among the best stocks to buy in November?

Harvey Jones is blown away by this resilient FTSE 100 growth share. Is it one of the best stocks to buy right now, or have investors missed their moment?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Two mid adult women enjoying a friends reunion city break for the weekend in Newcastle upon Tyne, England.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When looking for the best stocks to buy in the month ahead, I often start by checking what just happened in the one we’re just leaving behind.

One FTSE 100 name jumped out at me. Retail giant Next (LSE: NXT) ended October almost 17% higher, comfortably ahead of the second-best performer, drug maker GSK. I already hold GSK in my Self-Invested Personal Pension but sadly, I don’t hold Next. Probably because I never quite believed my eyes whenever I looked at its performance.

Retail is supposed to be a disaster zone. Whole chains have collapsed under the weight of the cost-of-living crisis, soaring rents, and the march of online shopping. April’s hike to employer’s National Insurance contributions and the minimum wage hikes have piled on more pressure. Yet through it all, Next keeps defying gravity. The shares are up 43% over the last year and 195% over three years, with dividends on top. It makes a mockery of Britain’s supposed retail gloom.

Yet more upbeat results

Every time I thought the run was too good to last, Next proved me wrong. The latest leap followed its third-quarter results on Wednesday (29 October), which thumped expectations yet again. Full-price sales rose 10.5% year on year in the 13 weeks to 25 October, more than double guidance for a 4.5% rise. UK sales were up 5.4%, overseas sales surged 38.8%, and management raised full-year profit guidance by £30m to £1.13bn.

Those numbers would be impressive in any climate, but especially now. Begbies Traynor’s Julie Palmer called Next “the gold standard in UK retail”, growing in a sector that’s struggling to stay afloat. It even benefited from a temporary online shutdown at rival Marks & Spencer after a cyber-attack, which sent some shoppers its way.

High-flying shares rarely come cheap. Next trades on a price-to-earnings ratio of 23.6, well above the market average of 18. Yet growth prospects are higher too. Analysts at Berenberg lifted their target price from 14,700p to 17,800p after the results, implying roughly 25% growth potential from today’s 14,265p.

The trailing dividend yield is a modest 1.6%, but there’s now a special payout of around £3.10 per share pencilled in for January 2026.

Next’s growing international footprint also makes it more resilient, giving it reach well beyond the UK’s fragile high streets. It’s a textbook example of how to evolve and survive in a tough market.

Time to take a look

Next isn’t just a single-brand story, so investors shouldn’t fixate on that. It owns UK rights to Gap and Victoria’s Secret, and holds stakes in Reiss, Joules, FatFace, and others. That portfolio gives it multiple ways to grow, especially if inflation and interest rates start easing, leaving shoppers with a bit more to spend.

Given its relentless run, I can’t call Next a bargain. Personally, I still prefer to target underperforming companies that are potentially on the cusp of recovery. I can see plenty of them out there, and they will be top of my shopping list in November.

Yet, I’m wildly impressed by Next’s discipline, innovation, scale, and resilience in tough times. I think investors could still consider buying Next shares with a long-term view. This unsung hero is beating the market in style.

Harvey Jones has positions in GSK. The Motley Fool UK has recommended Begbies Traynor Group Plc and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

Be greedy when others are fearful: 2 shares to consider buying right now

Warren Buffett says investors should be greedy when others are fearful. So do falling prices mean it’s time to buy…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Is Palantir still a millionaire-maker S&P 500 stock today?

Palantir has skyrocketed in recent years, making savvy investors a fortune. With the S&P 500 stock down 32% since November,…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

Pennies from an all-time low, is the Aston Martin share price poised to rebound?

How can a business with a great brand and rich customer base keep losing money? Christopher Ruane examines the conundrum…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

With spare cash to invest, does it make more sense to use a SIPP or an ISA?

ISA or SIPP? That's the dilemma this writer faces when trying to decide how to buy shares. So, what sort…

Read more »

Group of friends meet up in a pub
Investing Articles

Are barnstorming Barclays shares still a slam-dunk buy?

Barclays shares have had a blockbuster run but Harvey Jones now questions just how long the FTSE 100 bank can…

Read more »

Close-up of British bank notes
Investing Articles

5 steps to target a £5,000 second income

What would it really take to earn a second income of hundreds of pounds per month from dividend shares? Christopher…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is it madness to bet against the Rolls-Royce share price?

Harvey Jones wonders if the Rolls-Royce share price has flown too high, and it's finally time for investors to stand…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

A once-in-a-decade opportunity to buy quality UK shares?

As some of the UK’s top shares of the last 10 years fall to record low multiples, is this the…

Read more »